4.5 Article

Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy

Journal

INFLAMMATION
Volume 39, Issue 3, Pages 1238-1252

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10753-016-0359-6

Keywords

inflammation; T helper 1; cardiomyopathy; CXCL10; PDE5 inhibition

Funding

  1. Ministry of Research MIUR [RBAP109BLT, RBFR10URHP]

Ask authors/readers for more resources

T helper 1 (Th1) type cytokines and chemokines are bioactive mediators in inflammation underling several diseases and co-morbid conditions, such as cardiovascular and metabolic disorders. Th1 chemokine CXCL10 participates in heart damage initiation/progression; cardioprotection has been recently associated with sildenafil, a type 5 phosphodiesterase inhibitor. We aimed to evaluate the effect of sildenafil on CXCL10 in inflammatory conditions associated with diabetic cardiomyopathy. We analyzed: CXCL10 gene and protein in human cardiac, endothelial, and immune cells challenged by pro-inflammatory stimuli with and without sildenafil; serum CXCL10 in diabetic subjects at cardiomyopathy onset, before and after 3 months of treatment with sildenafil vs. placebo. Sildenafil significantly decreased CXCL10 protein secretion (IC50 = 2.6 x 10(-7)) and gene expression in human cardiomyocytes and significantly decreased circulating CXCL10 in subjects with chemokine basal level a parts per thousand yen 930 pg/ml, the cut-off value as assessed by ROC analysis. In conclusion, sildenafil could be a pharmacologic tool to control CXCL10-associated inflammation in diabetic cardiomyopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of androgens, estrogens, glucocorticoids and progestagens in human serum

Michele Iannone, Anna Pia Dima, Francesca Sciarra, Francesco Botre, Andrea M. Isidori

Summary: We present a LC-MS/MS method for simultaneous analysis of 16 endogenous steroids in human serum. The method is specific, linear, and can be used to identify concentration abnormalities in disorders of the gonadal and adrenal axes.

BIOMEDICAL CHROMATOGRAPHY (2022)

Article Biochemistry & Molecular Biology

Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson's and Alzheimer's Disease Patients

Anna Di Maio, Arianna De Rosa, Silvia Pelucchi, Martina Garofalo, Benedetta Marciano, Tommaso Nuzzo, Fabrizio Gardoni, Andrea M. Isidori, Monica Di Luca, Francesco Errico, Andrea De Bartolomeis, Elena Marcello, Alessandro Usiello

Summary: This study examined mRNA and protein expression of key spine shaping proteins in the brains of schizophrenia patients and found altered expression of CAP2 and DLG1 genes in different brain regions, suggesting their potential involvement in synaptic dysfunction associated with psychiatric disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

Phosphatidylserine Liposomes Reduce Inflammatory Response, Mycobacterial Viability, and HIV Replication in Coinfected Human Macrophages

Noemi Poerio, Nadia R. Caccamo, Marco P. La Manna, Tommaso Olimpieri, Lucia Henrici De Angelis, Marco M. D'Andrea, Francesco Dieli, Maurizio Fraziano

Summary: This study demonstrated the therapeutic potential of phosphatidylserine-liposome (PS-L) in the treatment of Mycobacterium tuberculosis-human immunodeficiency virus (HIV) coinfection. PS-L reduced inflammation and cytokine production, leading to a significant decrease in intracellular M. tuberculosis viability and HIV replication.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Engineering, Biomedical

Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients

Maria Tredicine, Francesco Ria, Noemi Poerio, Matteo Lucchini, Assunta Bianco, Federica De Santis, Mariagrazia Valentini, Valeria De Arcangelis, Mario Rende, Anna Maria Stabile, Alessandra Pistilli, Chiara Camponeschi, Viviana Nociti, Massimiliano Mirabella, Maurizio Fraziano, Gabriele Di Sante

Summary: The current available treatments of Multiple Sclerosis (MS) have limited efficacy in slowing the progression of the disease and can lead to severe side effects. This study evaluated the immunomodulatory potential of a new class of nanoparticles called liposomes in vitro. The results showed that liposomes composed of phosphatidylserine were able to inhibit inflammatory cytokine secretion and expand regulatory T cells. These findings suggest that liposomes could be used as therapeutic tools to dampen pro-inflammatory immune responses and promote regulatory immune responses in MS.

BIOMATERIALS (2023)

Review Nutrition & Dietetics

Gluten-Free Diet and Metabolic Syndrome: Could Be a Not Benevolent Encounter?

Giuseppe Defeudis, Maria Chiara Massari, Giovanni Terrana, Lucia Coppola, Nicola Napoli, Silvia Migliaccio

Summary: Celiac disease is increasingly being diagnosed, and the only available treatment is a gluten-free diet (GFD). The impact of gluten on metabolic syndrome and related inflammatory response is still uncertain due to conflicting results. Research on the role of the GFD in glycometabolic parameters, vitamin D, and inflammatory cytokines is necessary. This narrative review provides evidence on the effects of the GFD on various metabolic parameters, but the overall impact on metabolic syndrome components remains unclear.

NUTRIENTS (2023)

Review Nutrition & Dietetics

New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food

Donatella Ambroselli, Fabrizio Masciulli, Enrico Romano, Giuseppina Catanzaro, Zein Mersini Besharat, Maria Chiara Massari, Elisabetta Ferretti, Silvia Migliaccio, Luana Izzo, Alberto Ritieni, Michela Grosso, Caterina Formichi, Francesco Dotta, Francesco Frigerio, Eleonora Barbiera, Anna Maria Giusti, Cinzia Ingallina, Luisa Mannina

Summary: The definition of metabolic syndrome (MetS) has changed over time due to the difficulty in establishing universal criteria. MetS is associated with a pro-inflammatory state related to altered glucose metabolism, leading to increased cardiovascular risk. Complications of MetS include cardiovascular diseases (CVDs) and type 2 diabetes (T2D). Genetic factors, human microbiota, and diet play complex roles in the predisposition to MetS. This review summarizes the literature of the past decade on MetS, including its definition, pathophysiology, treatment approaches, prediction and diagnosis using advanced methodologies, and the role of specific foods in prevention and/or treatment.

NUTRIENTS (2023)

Review Biochemistry & Molecular Biology

An Update on Circular RNA in Pediatric Cancers

Angela Galardi, Marta Colletti, Alessandro Palma, Angela Di Giannatale

Summary: Circular RNAs (circRNAs), formed by reverse splicing of mRNAs, are noncoding RNA molecules with high stability, abundance, and evolutionary conservation. They play important roles in various cellular functions, including miRNA and protein sponges, transcriptional modulation, and splicing. Their aberrant expression in pathological conditions highlights their potential as diagnostic and prognostic biomarkers.

BIOMEDICINES (2023)

Review Medicine, General & Internal

The Dark Side of Ultrasound Imaging in Parathyroid Disease

Roberta Centello, Franz Sesti, Tiziana Feola, Valentina Sada, Carla Pandozzi, Marco Di Serafino, Patrizia Pacini, Vito Cantisani, Elisa Giannetta, Maria Grazia Tarsitano

Summary: This article provides a comprehensive review of the applications of ultrasound (US) in clinical practice, discussing the histopathological and US characteristics of the parathyroid glands in normal and pathological conditions, the advantages of preoperative imaging, and novel updates on the most useful and currently available multiparameter US techniques.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by Mycobacterium abscessus: Chitosan or e-Poly-L-Lysine Decoration

Jacopo Forte, Patrizia Nadia Hanieh, Noemi Poerio, Tommaso Olimpieri, Maria Grazia Ammendolia, Maurizio Fraziano, Maria Gioia Fabiano, Carlotta Marianecci, Maria Carafa, Federico Bordi, Simona Sennato, Federica Rinaldi

Summary: Mycobacterium abscessus (Mabs) is a dangerous non-tubercular mycobacterium with wide resistance to antibiotics, making therapeutic management difficult. Liposomes as nanocarriers can be modified to enhance stability, mucus penetration, and residence time in the lung. The study demonstrates the potential use of e-PLL liposomes for improving antibiotic delivery against Mabs infection.

BIOMOLECULES (2023)

Review Rheumatology

Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on 'Diagnosis, risk stratification, and continuity of care of fragility fractures' based on a systematic literature review

Silvia Migliaccio, Antimo Moretti, Annalisa Biffi, Raffaella Ronco, Gloria Porcu, Giovanni Adami, Rosaria Alvaro, Riccardo Bogini, Achille Patrizio Caputi, Luisella Cianferotti, Bruno Frediani, Davide Gatti, Stefano Gonnelli, Andrea Lenzi, Salvatore Leone, Tiziana Nicoletti, Marco Paoletta, Annalisa Pennini, Eleonora Piccirilli, Raffaella Michieli, Umberto Tarantino, Maurizio Rossini, Giovanni Corrao, Maria Luisa Brandi, Giovanni Iolascon

Summary: This article summarizes the results of a systematic review that examined the association between the continuity of medication treatment and various outcomes in patients with fragility fractures. The findings indicate that adherence to antiosteoporotic drugs can reduce the risk of nonvertebral fractures and refracture, and improve survival rates in patients who continue treatment. Therefore, clinicians should encourage patients to adhere to antiosteoporotic medication.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

Review Rheumatology

Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients

Antimo Moretti, Sara Liguori, Marco Paoletta, Silvia Migliaccio, Giuseppe Toro, Francesca Gimigliano, Giovanni Iolascon

Summary: Bone fragility is associated with aging, comorbidities, disability, poor quality of life, and increased mortality. International guidelines recommend a nutritional approach for managing patients with bone fragility, focusing on optimal protein, calcium, and vitamin D intake. Patients with major fragility fractures often have poor dietary habits and lack intake of nutrients that affect bone health, which can be further worsened during the COVID-19 pandemic. This narrative review discusses the role of macro- and micronutrients in patients with bone fragility during this pandemic.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

Review Biochemistry & Molecular Biology

Vitamin D as a Shield against Aging

Cristina Fantini, Clarissa Corinaldesi, Andrea Lenzi, Silvia Migliaccio, Clara Crescioli

Summary: Aging is a natural and unavoidable process that is characterized by the accumulation of biomolecular damage and defective cellular components, resulting in weakened overall body function. Aging is associated with changes in immune system cells, leading to a decline in immune surveillance and an increased risk of inflammation and oxidative stress-related diseases. Nutrition, including micronutrients like vitamins and elements, can play a role in regulating the aging process by impacting cell function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Rheumatology

Nutritional and physical activity issues in frailty syndrome during the COVID-19 pandemic

Maria Chiara Massari, Viviana Maria Bimonte, Lavinia Falcioni, Antimo Moretti, Carlo Baldari, Giovanni Iolascon, Silvia Migliaccio

Summary: 'Frailty' is a state of increased vulnerability caused by impairment of homeostasis due to stress. Frail individuals are more likely to experience significant health decline and have a higher risk of adverse outcomes such as osteoporosis, falls, and disability. Frailty is becoming increasingly important due to global population aging. The pathophysiology of frailty involves cumulative molecular and cellular damage and is partially independent of aging but closely related. Uncorrected nutrition and sedentary behavior worsen frailty.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

Meeting Abstract Oncology

ABROGATION OF EXOSOME BIOGENESIS SIGNIFICANTLY AFFECTS CELL MOTILITY IN HETEROGENOUS SUB-POPULATIONS OF PAEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMA

Giulia Pericoli, Angela Galardi, Lucia Lisa Petrilli, Alessandro Paolini, Stefano Levi Mortera, Gerardo Pepe, Alessandro Palma, Emmanuel de Billy, Roberta Ferretti, Marta Colletti, Ezio Giorda, Anna Burford, Alan Mackay, Luisa Pascucci, Hector Peinado, Chris Jones, Manuela Helmer Citterich, Lorenza Putignani, Andrea Carai, Angela Mastronuzzi, Andrea Masotti, Franco Locatelli, Angela Di Giannatale, Maria Vinci

NEURO-ONCOLOGY (2022)

Article Endocrinology & Metabolism

Angiogenic factors as prognostic markers in neuroendocrine neoplasms

Giulia Puliani, Franz Sesti, Emanuela Anastasi, Monica Verrico, Maria Grazia Tarsitano, Tiziana Feola, Federica Campolo, Cira Rosaria Tiziana Di Gioia, Mary Anna Venneri, Antonio Angeloni, Marialuisa Appetecchia, Andrea Lenzi, Andrea Marcello Isidori, Antongiulio Faggiano, Elisa Giannetta, Domenico Alvaro, Domenico Alvaro, Emanuela Anastasi, Antonio Angeloni, Oreste Bagni, Caterina Bangrazi, Massimiliano Bassi, Mario Bezzi, Nadia Bulzonetti, Vito Cantisani, Roberto Caronna, Giovanni Casella, Carlo Catalano, Roberta Centello, Enrico Cortesi, Ferdinando D'Ambrosio, Carlo Della Rocca, Adriano De Santis, Cira Rosaria Tiziana Di Gioia, Valentina Di Vito, Antongiulio Faggiano, Tiziana Feola, Daniele Gianfrilli, Alfredo Genco, Elisa Giannetta, Franco Iafrate, Andrea M. Isidori, Andrea Lenzi, Paolo Marchetti, Francesca Maccioni, Alessio Molfino, Maurizio Muscaritoli, Carla Pandozzi, Giulia Puliani, Franz Sesti, Carola Severi, Silverio Tomao, Vincenzo Tombolini, Federico Venuta, Monica Verrico

Summary: This study found higher levels of angiogenic markers in patients with NENs and an association between ANG2 serum levels and NENs morphology and staging. In both GEP and lung NENs, ANG2 and PROK2 were higher in cases of tumor progression, suggesting a potential role as prognostic markers in NENs patients.

ENDOCRINE (2022)

No Data Available